Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/108966) titled 'CYP3A5 Genotype and Hyperglycemia in Kidney Transplant' on April 21.
Study Type: Observational
Study Design:
Other Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: InvestigatorInitiated Study
Condition:
Health Condition 1: N186- End stage renal disease
Intervention:
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 29-05-2026
Target Sample Size: 60
Countries of Recruitment:
India
To know more, visit http://www.ct...